References
Reference
Waller P. Getting to grips with the new European Union pharmacovigilance legislation. Pharmacoepidemiol Drug Saf. Epub 2011 Mar 10
References
NHS Confederation. Where next for NHS reform? A discussion paper April 2011. 2011 April 6 [online]. Available from URL: http://www.nhsconfed.org/Publications/Documents/NHS_reform_discussion_paper_0411.pdf [Accessed 2011 Apr 26]
Hawkes N. Health secretary will pause and listen to staff over reform bill. BMJ 2011; 342: d2216
Triggle N. PM seeks to allay fears, but insists change is needed. 2011 April 6 [online]. Available from URL: http://www.bbc.co.uk [Accessed 2011 Apr 26]
Reference
Stremikis K, Schoen C, Fryer A-K. A call for change: The 2011 Commonwealth Fund survey of public views of the U.S. health system. 2011 Apr 11 [online]. Available from URL: http://www.commonwealthfund.org [Accessed 2011 Apr 26]
Reference
Houston M. New government is to introduce universal primary care for Ireland. BMJ 2011; 342: d1825
Reference
Sweet M. Australia makes a start on primary healthcare reform, at last. BMJ 2011; 342: d1341
Reference
Government of Canada. Regulations amending the food and drug regulations (adverse drug reaction reporting). 2011 Feb 10 [online]. Available from URL: http://www.gazette.gc.ca/rp-pr/p2/2011/2011-03-02/html/sor-dors31-eng.html [Accessed 2011 Apr 26]
Reference
Weiss-Smith S, Deshpande G, Chung S, et al. The FDA drug safety surveillance program: adverse event reporting trends. Arch Intern Med 2011; 171 (6): 591–3
References
Hawkes N. Value based drug pricing could increase NHS drugs bill. BMJ 2011; 342: d1759
National Institute for Health and Clinical Excellence. NICE responds to government’s plans to introduce value-based pricing. 2011 Mar 21 [online]. Available from URL: http://www.nice.org.uk/newsroom/news/NICERespondsToGovernmentsPlansToIntroduceValueBasedPricing.jsp [Accessed 2011 Apr 26]
Reference
WHO. Vigibase reaches 6million reports [media release]. 2011 Feb 23 [online]. Available from URL: http://www.who-umc.org [Accessed 2011 Apr 26]
Reference
National Institute for Health and Clinical Excellence. NICE welcomes National Prescribing Centre [media release]. 2011 Apr 1 [online]. Available from URL: http://www.nice.org.uk/newsroom/pressreleases/NICEWelcomesNPC.jsp [Accessed 2011 Apr 26]
Reference
European Commission. Pricing and reimbursement of medicines: Commission consults on EU transparency rules [media release]. 2011 Mar 28 [online]. Available from URL: http://ec.europa.eu/enterprise/newsroom/cf/itemlongdetail.cfm?displayType=news&item_id=5006&tpa_id=0 [Accessed 2011 Apr 26]
Reference
Grogan K. PhRMA blasts Obama over pay-for-delay ban plan. 2011 Feb 15 [online]. Available from URL: http://www.pharmatimes.com [Accessed 2011 Apr 26]
References
Mashta O. Herbal medicines will need to be registered with drug regulator to be sold in UK. BMJ 2011; 342: d1733
MHRA. Press release: 100th traditional herbal registration granted [media release]. 2011 Mar 18 [online]. Available from URL: http://www.mhra.gov.uk/NewsCentre/Pressreleases/CON111687 [Accessed 2011 Apr 26]
Reference
Medicines and Healthcare Products Regulatory Agency. Best practice in reporting of individual case safety reports (ICSRs). 2011 Feb 17. Available from URL: http://www.mhra.gov.uk/Publications/Regulatoryguidance/Medicines/Othermedicinesregulatoryguidance/CON108807 [Accessed 2011 Apr 26]
Reference
National Institute for Health and Clinical Excellence. NICE pilot diagnostics project points way forward for evaluation of diagnostic technologies [media release]. 2011 Mar 25 [online]. Available from URL: http://www.nice.org.uk/newsroom/pressreleases/DAPPilot.jsp [Accessed 2011 Apr 26]
Reference
Canadian Agency for Drugs and Technologies in Health. The Economic Value of Innovative Health Technologies: discussion paper. 2011 Feb [online]. Available from URL: http://www.cadth.ca/media/pdf/H0495_Economic_Value_of_Innovative_Health_Technology-e.pdf [Accessed 2011 Apr 26]
Reference
Prescription Solutions. The explosive specialty pharmaceuticals market: who gets, who pays, who decides? [media release]. 2011 Apr 1 [online]. Available from URL: http://www.prescriptionsolutions.com [Accessed 2011 Apr 27]
Reference
Express Scripts. Harnessing patients good intentions can cut 33% of America’s pharmacy-related waste [media release]. 2011 Apr 7 [online]. Available from URL: http://www.express-scripts.com [Accessed 2011 Apr 27]
Reference
Coloma PM, Schuemie MJ, Trifiro G, et al. Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project. Pharmacoepidemiol Drug Saf 2011; 20 (1): 1–11
References
Knezevic MZ, Bivolarevic IC, Peric TS, Jankovic SM. Using Facebook to increase spontaneous reporting of adverse drug reactions. Drug Saf 2011; 34 (4): 351–2
Edwards IR, Lindquist M. Social media and networks in pharmacovigilance: boon or bane? Drug Saf 2011 34 (4): 267–71
References
European Parliament. The news: migrant upsurge — fake drugs (video presentation). 2011 [online]. Available from URL: http://www.europarl.europa.eu/en/headlines/content/20110211MUN13588 [Accessed 2011 April 27]
Watson R. European Union clamps down on fake drugs. BMJ 2011; 342: d1198
Reference
Zarocostas J. Patent rules must not hinder access to cheap drugs in poor countries, experts say. BMJ 2011; 342: d1219
Reference
Michelis KC, Hassouna B, Owlia M, et al. Effect of electronic prescription on attainment of cholesterol goals. Clin Cardiol 2011; 34 (4): 254–60
Reference
Chambers JD, Neumann PJ. Listening to Provenge — what a costly cancer treatment says about future Medicare policy. New Eng J Med. Epub 2011 Apr 6
Reference
Zarocostas J. Poor countries should use flexibility in global trade agreement to improve access to antiretrovirals, says report. BMJ 2011; 342: d1677
Reference
Hsiao WC. State-based, single-payer health care — a solution for the United States? N Engl J Med 2011; 364 (13): 1188–90
Reference
Premier Inc. Drug shortages cost care providers at least $200 million annually, pose patient safety risks, research suggests [media release]. 2011 Mar 29 [online]. Available from URL: http://www.premierinc.com/about/news/11-mar/drugshortage032811.jsp [Accessed 2011 Apr 27]
Reference
Mudur G. India’s proposed pact with Europe may choke its generic drug exports, health rights activists fear. BMJ 2011; 342: d1480
References
Schramm TK, Gislason GH, Vaag A, et al. Mortality and cardiovascular risk associated with different insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous myocardial infarction: a nationwide study. Eur Heart J. Epub 2011 Apr 6
Gore MO, McGuire DK. Resolving drug effects from class effects among drugs for type 2 diabetes mellitus: more support for cardiovascular outcome assessments. Eur Heart J. Epub 2011 Apr 6
Reference
European Medicines Agency. European Medicines Agency concludes class review of bisphosphonates and atypical fractures [media release]. 2011 Apr 15 [online]. Available fromURL: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2011/04/WC500105281.pdf [Accessed 2011 Apr 27]
Reference
Huang CC, Chan WL, Chen YC, et al. Angiotensin II receptor blockers and risk of cancer in patients with systemic hypertension. Am J Cardiol 2011; 107 (7): 1028–33
Rights and permissions
About this article
Cite this article
Forum. Pharm Med 25, 189–198 (2011). https://doi.org/10.1007/BF03256860
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03256860